Clinical Trials Browser

Phase EARLY_PHASE1 × Interleukin-2 × 90 days × Clear all

NCT06318871 2026-05-11

Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma

Phase EARLY_PHASE1 Active not recruiting

Carcinoma, Renal Cell, Carcinoma, Transitional Cell